#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Anti-glomerular basement membrane disease Conjunctivitis allergic Cardiac failure acute Demyelination Epidermolysis bullosa Phaeochromocytoma Henoch-Schonlein purpura Neutropenia Necrotising myositis Retinopathy proliferative Kawasaki's disease Lip and/or oral cavity cancer Cholangiocarcinoma Candida infection Neuroendocrine carcinoma metastatic More trials…

    Learn about Rare Diseases

    Glomerulonephritis membranoproliferative – Trials in Disease Pulmonary sarcoidosis – Treatment Waldenstrom’s macroglobulinaemia refractory – Diagnostics Pyogenic sterile arthritis pyoderma gangrenosum and acne syndrome – Basic Information Pulmonary fibrosis – Basic Information Anaplastic thyroid cancer – Trials in Disease Hereditary optic atrophy – Diagnostics Ornithine transcarbamoylase deficiency – Treatment Angiosarcoma – Treatment Propionic acidaemia – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Amitriptyline Azacitidine Peppermint Oil Hydrochlorothiazide Tioguanine Acoramidis Hydrochloride Calcium Oxybate SODIUM SULFIDE NONAHYDRATE Tipiracil Hydrochloride RP3 Nmd670 OSIMERTINIB MESYLATE RIKKUNSHITO Pozelimab Arginine Omx-0407 Mosaic Hbcoreag Taplucainium Chloride HLX43 Romiplostim More therapies…

    Learn about Your Condition

    Asthma COVID-19 Urethral valves Hepatitis alcoholic Myasthenia gravis Food allergy Deafness Oesophageal achalasia Endometrial cancer stage IV Endocrine disorder Cardiogenic shock Mantle cell lymphoma stage II Adenomyosis Schizophrenia Hepatic encephalopathy More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Study on Desflurane, Sevoflurane, and Propofol for Postoperative Delirium in Elderly Patients Undergoing Major Abdominal Surgery

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Postoperative delirium
    Investigated Drugs:
    • Desflurane
    • Sevoflurane
    • Propofol
    Austria

  • Study on Deucravacitinib for Children with Moderate to Severe Plaque Psoriasis

    Recruiting

    3 1
    Investigated Diseases:
    • Psoriasis
    Investigated Drugs:
    • Deucravacitinib
    France Germany Poland Romania Spain

  • Study of Microdystrophin (GNT0004) Gene Therapy for Duchenne Muscular Dystrophy in Boys Who Can Walk

    Recruiting

    2 1 1
    Investigated Drugs:
    • Adeno-Associated Viral Vector Serotype 8 Containing The Human Md1 Gene
    • Potassium Chloride
    • Sirolimus
    Belgium France Spain

  • Study on the Effectiveness and Safety of Cisplatin and Paclitaxel in Advanced Ovarian Cancer Patients After Surgery

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Ovarian cancer
    Investigated Drugs:
    • Cisplatin
    • Paclitaxel
    Spain

  • Study on Ravulizumab for Children Aged 6 to 17 with Generalized Myasthenia Gravis

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Ravulizumab
    France Italy The Netherlands Spain

  • Study on Preoperative Treatment for HER2-Negative Breast Cancer Using Pembrolizumab, Paclitaxel, and Carboplatin in Patients Not Responding to Initial Chemotherapy

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • HER2 negative breast cancer
    Investigated Drugs:
    • Carboplatin
    • Paclitaxel
    • Pembrolizumab
    Poland
Previous Page
1 … 590 591 592 593 594 … 1,655
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!